Adriana Olar to Glioma
This is a "connection" page, showing publications Adriana Olar has written about Glioma.
Connection Strength
2.661
-
Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Semin Radiat Oncol. 2015 Jul; 25(3):155-63.
Score: 0.460
-
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
Score: 0.459
-
Molecular classification of diffuse gliomas. Oncology (Williston Park). 2013 Jun; 27(6):514, 518, 520.
Score: 0.408
-
Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol. 2012 Dec; 13(4):417-36.
Score: 0.394
-
Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70.
Score: 0.369
-
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types. Neuropathol Appl Neurobiol. 2022 12; 48(7):e12847.
Score: 0.194
-
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course. Acta Neuropathol. 2020 01; 139(1):193-209.
Score: 0.158
-
Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.
Score: 0.125
-
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9.
Score: 0.094